双类阿片类神经类FF小分子体表现出降低耐受性负债的止痛作用
Marco Mottinelli1,2, V Blair Journigan1, Samuel Obeng3
1Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.
Molecules (Basel, Switzerland)
|July 12, 2025
概括
双作用阿片类神经FF (NPFF) 受体连接体提供有前途的缓解疼痛. 化合物22b在没有吗啡的情况下显示出有效的抗受体.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 神经FF (NPFF) 受体对抗剂可以防止吗啡诱导的抗受体耐受性.
- 具有双重mu阿片类受体 (MOR) 激动剂和NPFF对抗剂活性的化合物可能在没有耐受性的情况下提供止痛作用.
研究的目的:
- 为了合成和评估新的双重作用的MOR激动剂/NPFF对抗剂化合物.
- 在体内评估这些化合物的抗毒感应疗效,副作用概况和耐受性发展.
主要方法:
- 放射性联体竞争结合试验和[35S]GTPγS功能试验被用于确定受体亲和度和功能概况.
- 在小鼠体内研究评估了抗受,预防NPFF诱导的过敏症,呼吸抑制,超位运动和肠道过渡.
- 对有希望的化合物进行了药理动力学和微体稳定性研究.
主要成果:
- 化合物22b证明了剂量依赖的MOR介导的抗受体,并预防了NPFF诱导的过敏症.
- 化合物22b与吗啡不同,没有引起呼吸抑制,超位运动或肠道通道受损.
- 与吗啡相比,重复使用22b的治疗显示出与吗啡相比,抗受体耐受性明显较低,具有有利的药理学特性.
结论:
- 双重作用的阿片类药物-NPFF配体,如化合物22b,代表了对止痛的有前途的治疗策略.
- 与传统阿片类药物相比,这些化合物可以提供有效的疼痛管理,降低耐受性和副作用的责任.
相关概念视频
Analgesia and Pain Management
811
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
811
Opioid Analgesics: Synthetic and Semisynthetic Opioids
438
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
438
Opioid Receptors: Overview
1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Opioid Analgesics: Morphine and Other Natural Cogeners
373
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
373
Local Anesthetics: Differential Sensitivity of Nerve Fibers
940
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
940
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K


